Literature DB >> 8139269

Colocalization of myocardial fibrosis and inflammatory cells in rats.

N Hinglais1, D Heudes, A Nicoletti, C Mandet, M Laurent, J Bariéty, J B Michel.   

Abstract

BACKGROUND: Left ventricular overload and aging lead to an increase in fibrosis in the rat cardiac interstitium. The relationship between fibrosis, fibroblast activity, and inflammatory cell infiltration, was explored in spontaneously hypertensive rats (SHR) and Wistar controls. EXPERIMENTAL
DESIGN: The left ventricle of three groups of eight SHR and eight Wistar controls hearts were sectioned for light microscopy, immunohistochemistry, and in situ hybridization with a cDNA probe encoding the murine alpha 1 chain of type I collagen. Fibrosis was measured morphometrically. Monoclonal antibodies directed against Ia antigen, CD8+ cytotoxic, CD4+ helper lymphocytes and monocyte/macrophages were used to localize and quantify the inflammatory cells.
RESULTS: In 2-month-old rats, with nearly normal interstitial cardiac tissue, fibroblasts expressing collagen mRNA were located around coronary vessels. The areas of fibrosis and interstitial cellular infiltration were more extensive in 22-month-old rats than in 12-month-old rats and greater in SHR than in Wistar. Fibroblasts expressing collagen mRNA were mainly found at the border between fibrosis and myocytic cells, and were always colocalized with lymphocytes and macrophages. The interstitial areas of fibrosis and collagen I expressing fibroblasts had the same pattern of infiltrating cells in normotensive rats than in SHR. Fibrosis and the density of macrophages and CD4+ lymphocytes were correlated.
CONCLUSIONS: Thus, fibroblast activity could be closely related to the presence of lymphocytes and macrophages in the myocardium of spontaneously hypertensive and aged rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139269

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  29 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats.

Authors:  Shan-Shan Xing; Xiu-Ping Bi; Hong-Wei Tan; Yun Zhang; Qi-Chong Xing; Wei Zhang
Journal:  Mol Med       Date:  2010-07-12       Impact factor: 6.354

Review 3.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

4.  Molecular and ultrastructural studies of the fibrotic lesions of bovine focal proliferative fibrogranulomatous panniculitis (Lechiguana).

Authors:  G B Andrade; S L Ladeira; C N Battlehner; P H N Saldiva; E G Caldini
Journal:  Vet Res Commun       Date:  2007-05-11       Impact factor: 2.459

5.  In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats.

Authors:  S Nakatsuji; J Yamate; M Kuwamura; T Kotani; S Sakuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

6.  IκBβ attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice.

Authors:  Shanqin Xu; Hui Zhi; Xiuyun Hou; Richard A Cohen; Bingbing Jiang
Journal:  Hypertension       Date:  2011-06-06       Impact factor: 10.190

Review 7.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.

Authors:  N Glezeva; J A Baugh
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

8.  Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase.

Authors:  J Hou; H Kato; R A Cohen; A V Chobanian; P Brecher
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 9.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

10.  Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.

Authors:  Saman Rasoul; Oscar A Carretero; Hongmei Peng; Maria A Cavasin; Jialong Zhuo; Alicia Sanchez-Mendoza; David R Brigstock; Nour-Eddine Rhaleb
Journal:  J Hypertens       Date:  2004-03       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.